Differential expression of the inflammatory ciita gene may be accompanied by altered bone properties in intact sex steroid-deficient female rats

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,93 MB, PDF-dokument

Objective
The class II transactivator (CIITA), encoded by the CIITA gene, controls expression of immune response regulators, which affect bone homeostasis. Previously, we investigated a functional CIITA polymorphism in elderly women. Women carrying the allele associated with lower CIITA levels displayed higher bone mineral density (BMD), but also higher bone loss. The present exploratory study in a rat model sought to investigate effects of differential expression of Ciita on bone structural integrity and strength. Two strains DA (normal-to-high expression) and DA.VRA4 (lower expression) underwent ovariectomy (OVX) or sham-surgery at ~ 14-weeks of age (DA OVX n = 8, sham n = 4; DA.VRA4 OVX n = 10, sham n = 2). After 16-weeks, femoral BMD and bone mineral content (BMC) were measured and morphometry and biomechanical testing performed.

Results
In DA.VRA4 rats, BMD/BMC, cross-sectional area and biomechanical properties were lower. Ciita expression was accompanied by OVX-induced changes to cross-sectional area and femoral shaft strength; DA rats had lower maximum load-to-fracture. Thus, while lower Ciita expression associated with lower bone mass, OVX induced changes to structural and mechanical bone properties were less pronounced.

Conclusion
The data tentatively suggests association between Ciita expression and structural and mechanical bone properties, and a possible role in bone changes resulting from estrogen deficiency.
OriginalsprogEngelsk
Artikelnummer372
TidsskriftBMC Research Notes
Vol/bind16
Udgave nummer1
Antal sider7
ISSN1756-0500
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
Lund University Bioimaging Centre (LBIC), Lund University, is gratefully acknowledged for providing experimental resources for 3D-µCT scans and Marie Sydoff for technical assistance. The authors thank Tanja Hegner (Rigshospitalet, Glostrup, Dept of Clinical Biochemistry, Centre of Diagnostic Investigation, Glostrup, Denmark) for performing DXA scans and strength tests, and Zanne Henriksen, Charlotte Sewerin Larsen, Jette Stokholm, and Britt Corfixen (Rigshospitalet, Glostrup) for assistance with bioanalysis of serum and urine samples.

Funding Information:
This work was supported by grants from the Swedish Research Council (2018–02981), Greta and Johan Kock Foundation, Albert Påhlsson Foundation, Alfred Österlunds Foundation, the Herman Järnhardt foundation, King Gustav V:s 80-year foundation, The Swedish Rheumatism Association, The Stohnes Foundation, Skåne University Hospital Research Fund, Research and Development Council of Region Skåne, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Publisher Copyright:
© 2023, The Author(s).

ID: 379036422